KALA BIO, Inc.
KALA
$9.31
$0.536.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.16M | -8.95M | -8.18M | -8.95M | -9.58M |
| Total Depreciation and Amortization | 67.00K | 68.00K | 69.00K | 63.00K | 61.00K |
| Total Amortization of Deferred Charges | 173.00K | 186.00K | 299.00K | 322.00K | 315.00K |
| Total Other Non-Cash Items | 2.49M | 2.42M | 2.18M | 2.55M | 2.04M |
| Change in Net Operating Assets | 694.00K | -2.55M | 1.03M | 1.29M | -2.05M |
| Cash from Operations | -7.73M | -8.82M | -4.60M | -4.73M | -9.22M |
| Capital Expenditure | -16.00K | -- | -69.00K | -90.00K | -36.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -16.00K | -- | -69.00K | -90.00K | -36.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.53M | -28.00K | -5.03M | -18.00K | -- |
| Issuance of Common Stock | 0.00 | 13.00K | 11.67M | -- | 14.97M |
| Repurchase of Common Stock | -- | -- | -- | -162.00K | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -120.00K | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -2.53M | -135.00K | 6.65M | -180.00K | 14.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.28M | -8.96M | 1.98M | -5.00M | 5.72M |